(Q34547096)

2 August 2017

1 reference

title

Lithium treatment at 52. (English)

1 reference

2 August 2017

0 references

Schou M

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Journal of Affective Disorders

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

issue

1-3

1 reference

2 August 2017

page(s)

21-32

1 reference

Lithium Prophylaxis in Recurrent Affective Disorders

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

1 reference

7 January 2021

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Does lithium treatment still work? Evidence of stable responses over three decades

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Is there a loss of efficacy of lithium in patients treated for over 20 years?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prophylactic lithium: another therapeutic myth? An examination of the evidence to date

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Sixteen-year mortality in patients with affective disorder commenced on lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prophylactic lithium in affective disorders. Controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

A controlled evaluation of lithium prophylaxis in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Current therapeutic profile of lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Unanswered questions, unknown future for one of our oldest medications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Methodological Problems of Prophylactic Trials in Recurrent Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Admission rates and lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Designing long-term clinical trials in affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Has the effectiveness of lithium changed? Impact of the variety of lithium's effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The therapeutic effect of lithium carbonate on a patient with a forty-eight hour periodic psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prophylactic lithium in recurrent affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium and psychosis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The prophylactic efficacy of lithium--transient or persistent?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium revisited. A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium Maintenance: 1. A Standard Education Programme for Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Kidney functioning during lithium treatment: a prospective study of patients treated with lithium for up to ten years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Lithium: a brake in the rising cost of mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The treatment of manic psychoses by the administration of lithium salts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Admission rates and lithium therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prospective studies on a lithium cohort. 2. Renal function. Water and electrolyte metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The combat of non-compliance during prophylactic lithium treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Has the time come to abandon prophylactic lithium treatment? A review for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Treating recurrent affective disorders during and after pregnancy. What can be taken safely?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Discontinuation of maintenance treatment in bipolar disorder: risks and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Depression during mania. Treatment response to lithium or divalproex.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Avoidance of lithium intoxication: advice based on knowledge about the renal lithium clearance under various circumstances

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Effect of lithium maintenance on suicidal behavior in major mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2801%2900380-9

7 January 2021

10.1016/S0165-0327(01)00380-9

Identifiers

DOI

1 reference

2 August 2017

1 reference